Organon & Co. (OGN) Stock Price

OGNStock
$13.75+45.81%52W
Market Cap$3.61B
P/E19.27x
PEG Ratio
Div yield9.86%
Beta1.55

OGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)73.07%
Price vs S&P 500 (4W)-1.35%
VGM Score49.25
P/E Ratio (Annual)19.27x
Indicated Dividend Yield (Annual)9.86%

OGN Earnings Surprise History

Q2 251.00est. 0.94
Q3 251.01est. 0.93
Q4 250.63est. 0.73
Q1 260.71est. 0.85
Q2 260.85est. 1.07

OGN Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
2.54
2.46
2.46
2.46

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
OGNOrganon & Co.
BFB$13.75
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Organon & Co.

Organon & Co is a pharmaceutical company focused on women's health, biosimilars, and established brand medications. The majority of revenue comes from established brands, with geographic concentration in Europe and Canada, followed by the United States and Asia Pacific.